Top news of the week: 19.10.2022.
Is Technology Diversifying Biomedical R&D Outputs?
With advances in technology and their adoption occurring faster than ever before in all aspects of our lives, it is perhaps surprising that the field of biotechnology is only fairly ...
Enliven Takes Precision Oncology Ambitions Public In Merger With Imara
<p>The planned all-stock transaction will enable Enliven to take over Imara’s Nasdaq listing with cash runway into 2026. Imara shareholders get contingent value rights tied to sold-off top ...
Now Accepting Call For Sessions Proposals for the 2023 BIO International Convention
Now Accepting Call For Sessions Proposals for the 2023 BIO International Convention Showcase your thought leadership by speaking on or helping build a panel for the BIO 2023 program by ...
BeiGene's Brukinsa PFS Win Lifts China Biotech Stocks
<p><span>BeiGene's Brukinsa beats Imbruvica in top-line progression-free survival results from the Phase III head-to-head ALPINE trial in chronic lymphocytic leukemia or small lymphocytic ...
Josh Bilenker’s last biotech sold for $8 billion. His next one is cloaked in mystery but loaded with money
The big fundraising effort by Josh Bilenker and Jeffrey Engelman is likely to seed even more curiosity about what, exactly, is happening at their new company, Treeline.
SillaJen Soars As Korea Exchange Decides To Retain Listing
<p>The long-standing SillaJen saga in Korea appears close to ending following a decision that the company can maintain its stock market listing. Shares in the oncolytic virus firm surged by ...
Without a nasal vaccine, the U.S. edge in fighting Covid is on the line
Foreign rivals are developing vaccines that could stop transmission before the U.S., and that’s a potential biosecurity threat.
Lilly to Acquire Akouos to Discover and Develop Treatments for Hearing Loss
The Investor Relations website contains information about Eli Lilly and Company's business for stockholders, potential investors, and financial analysts.